Enforced GFI1 expression impedes human and murine leukemic cell growth
The differentiation of haematopoietic cells is regulated by a plethora of so-called transcription factors (TFs). Mutations in genes encoding TFs or graded reduction in their expression levels can induce the development of various malignant diseases such as acute myeloid leukaemia (AML). Growth Facto...
Gespeichert in:
Veröffentlicht in: | Scientific reports 2017-11, Vol.7 (1), p.15720-13, Article 15720 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The differentiation of haematopoietic cells is regulated by a plethora of so-called transcription factors (TFs). Mutations in genes encoding TFs or graded reduction in their expression levels can induce the development of various malignant diseases such as acute myeloid leukaemia (AML). Growth Factor Independence 1 (GFI1) is a transcriptional repressor with key roles in haematopoiesis, including regulating self-renewal of haematopoietic stem cells (HSCs) as well as myeloid and lymphoid differentiation. Analysis of AML patients and different AML mouse models with reduced
GFI1
gene expression levels revealed a direct link between low GFI1 protein level and accelerated AML development and inferior prognosis. Here, we report that upregulated expression of
GFI1
in several widely used leukemic cell lines inhibits their growth and decreases the ability to generate colonies
in vitro
. Similarly, elevated expression of
GFI1
impedes the
in vitro
expansion of murine pre-leukemic cells. Using a humanized AML model, we demonstrate that upregulation of
GFI1
expression leads to myeloid differentiation morphologically and immunophenotypically, increased level of apoptosis and reduction in number of cKit
+
cells. These results suggest that increasing GFI1 level in leukemic cells with low
GFI1
expression level could be a therapeutic approach. |
---|---|
ISSN: | 2045-2322 2045-2322 |
DOI: | 10.1038/s41598-017-15866-9 |